We are live on
!
Find out more
SGMO
SANGAMO THERAPEUTICS INC
SGMO
SGMO
Delisted
SGMO was delisted on the 4th of May, 2026.
111 hedge funds and large institutions have $26M invested in SANGAMO THERAPEUTICS INC in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $344K | Put options by funds: $315K
1% less capital invested
Capital invested by funds: $26.2M → $26M (-$134K)
Holders
111
Holding in Top 10
–
Calls
$344K
Puts
$315K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$2.1M | |
| 3 | +$694K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$615K |
| 5 |
Two Sigma Investments
New York
|
+$603K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.16M | |
| 3 | -$595K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$179K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$135K |
